IGBA - International Generic and Biosimilar medicines Association

https://lnkd.in/d-HF3mkj

📢 Mark your calendars for the 𝗕𝗶𝗼𝗲𝗾𝘂𝗶𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, #BIOEQ25! Dive into the evolving bioequivalence landscape with updates on global guidelines and regulatory harmonization. Don’t miss this chance to connect with international experts and shape the future of bioequivalence practices! 📅 26 February 2025 📍 Hilton Amsterdam Airport Schiphol Discover all the details and secure your spot: ➡️ Visit the conference page: https://lnkd.in/dDzgG29n Be part of the conversation—see you there! #BIOEQ25 #ICHM13 #Genericmedicines #pharmaceuticallegislation #Internationalharmonisationbioequivalence #ICHM15Guideline IGBA - International Generic and Biosimilar medicines Association, Susana Almeida, Nicolas Tascon G., Carlotta Cogoni Medicines for Europe, Adrian van den Hoven, Beata Stepniewska, Trudy Beks, Cristina Romagnoli, Lucia Romagnoli, Indiana Castro Alonso

The representatives of the IGBA CEO Advisory Committee – Ms. Vinita Gupta, Mr. Lucas Sigman, Mr. Richard Saynor, Ms. Susana Almeida and Mr. Sergio Napolitano – met with World Intellectual Property Organization – WIPO’s Director General – Mr. Daren Tang – and team to emphasize the importance of balanced #IntellectualProperty systems. We continue to work towards fostering systems that support both #innovation and #access to safe, efficacious, cost-effective, and quality assured medicines

The representatives of the IGBA CEO Advisory Committee – Ms. Vinita Gupta, Mr. Lucas Sigman, Mr. Richard Saynor, Ms. Susana Almeida and Mr. Sergio Napolitano – met with World Intellectual Property Organization – WIPO’s Director General – Mr. Daren Tang – and team to emphasize the importance of balanced #IntellectualProperty systems. We continue to work towards fostering systems that support both #innovation and #access to safe, efficacious, cost-effective, and quality assured medicines

Today, at the #2024MeetingwithManufacturersAndSuppliers, IGBA - International Generic and Biosimilar medicines Association’s Secretary General, Susana Almeida, spoke about the work that IGBA does, addressed ecosystemic issues, and proposed solutions for expanding access to quality health products through partnerships and systems strengthening. Among the areas requiring action are market #sustainability, divergent #regulatory requirements, limited supply chain #diversification, and unbalanced #IP systems. Solutions include encouragement of pro-competition policies, regulatory convergence and #harmonization, incentives to investments in manufacturing, robust #patent quality criteria. We believe this can be achieved through #partnerships and #collaborations based on trust, open and regular dialogue, and converging practical targets. Thanks to the World Health Organization, UNICEF, and United Nations Population Fund (UNFPA) for giving a space to the international voice of generic and biosimilar medicines suppliers and manufacturers!

Did you miss the #GlobalBiosimilarsWeek webinar on "Streamlining the Regulatory Process to Advance Access to Biosimilars"? Don't worry! You can still watch it in The Center for Biosimilars's Youtube channel here: https://lnkd.in/emq6bzSx

I couldn't be happier that the IGBA - International Generic and Biosimilar medicines Association is co-hosting with Medicines for Europe the 3rd #Bioequivalence Conference on 26 Feb 2025. The draft program is available now and the registration is open. These are exciting times for bioequivalence and I hope to see you in Amsterdam!

Starting the day in Copenhagen at the 2024 Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers. Happy to contribute on behalf of IGBA - International Generic and Biosimilar medicines Association and share views from the generic and biosimilar sector

It is with great pleasure that we invite you to the 3rd #Bioequivalence Conference scheduled to take place on 26 February 2025 as an in-person event at the Hilton Amsterdam Airport Schiphol, in Amsterdam, the Netherlands. This conference will provide a valuable opportunity to delve into the latest advancements in bioequivalence, exchange insights, and strengthen collaborations across the industry. Check it out!➡️https://lnkd.in/dDzgG29n #BIOEQ25 #ICHM13 #Genericmedicines #pharmaceuticallegislation #Internationalharmonisationbioequivalence #ICHM15Guideline IGBA - International Generic and Biosimilar medicines Association, Susana Almeida, Nicolas Tascon G., Carlotta Cogoni Medicines for Europe, Adrian van den Hoven, Beata Stepniewska, Trudy Beks, Cristina Romagnoli, Indiana Castro Alonso

A special thank you to our valued social media partners JackLeckerman ., BR&R, The Center for Biosimilars, Festival of Biologics, Generics and Biosimilars Initiative (GaBI), and Citeline, for helping to raise awareness around the successes and challenges of biosimilar medicines during #GlobalBiosimilarsWeek 2024! We appreciate you!  Daniela Huertas Stan Mehr Skylar Jeremias Emily Ngai Lasia Tang Ellie McCall